Resistance mutation supply modulates the benefit of CRISPR immunity against virulent phages (2025)
Attributed to:
Does CRISPR-Cas immunity limit the effectiveness of phage therapy?
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2025.10.05.680503
Publication URI: http://dx.doi.org/10.1101/2025.10.05.680503
Type: Preprint